Industry Growth Insights published a new data on “Contract Manufacture Organization (CMO) Market”. The research report is titled “Contract Manufacture Organization (CMO) Market research by Types (Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)), By Applications (Pharmaceutical Industry, Biotechnology, Medical Device Industry), By Players/Companies Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Contract Manufacture Organization (CMO) Market Research Report
By Type
Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)
By Application
Pharmaceutical Industry, Biotechnology, Medical Device Industry
By Companies
Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Contract Manufacture Organization (CMO) Market Report Segments:
The global Contract Manufacture Organization (CMO) market is segmented on the basis of:
Types
Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Biotechnology, Medical Device Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Boehringer Ingelheim
- Catalent
- Baxter
- AbbVie
- Pfizer
- Evonik
- Fareva group
- Aenova
- Almac
- Delpharm
- Recipharm
- Aesica
- NIPRO CORPORATION
- Daito Pharmaceutical
- Teva API
- Esteve Quimica
- Euticals
- Zhejiang Hisun Pharmaceuticals
Highlights of The Contract Manufacture Organization (CMO) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Active Pharmaceutical Ingredients (APIs)
- Finished Dose Formulations (FDFs)
- By Application:
- Pharmaceutical Industry
- Biotechnology
- Medical Device Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Contract Manufacture Organization (CMO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Contract Manufacture Organization (CMO) is a business model in which a company contracts with other companies to produce products or services. The contract manufacturer typically assembles the products or performs the services, but sometimes outsources certain components or tasks. The CMO can be an effective way to reduce costs and increase efficiency by leveraging economies of scale and specialization.
Some of the major companies in the contract manufacture organization (cmo) market are Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group, Aenova, Almac, Delpharm, Recipharm, Aesica, NIPRO CORPORATION, Daito Pharmaceutical, Teva API, Esteve Quimica, Euticals, Zhejiang Hisun Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contract Manufacture Organization (CMO) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Contract Manufacture Organization (CMO) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Contract Manufacture Organization (CMO) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Contract Manufacture Organization (CMO) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Contract Manufacture Organization (CMO) Market Size & Forecast, 2018-2028 4.5.1 Contract Manufacture Organization (CMO) Market Size and Y-o-Y Growth 4.5.2 Contract Manufacture Organization (CMO) Market Absolute $ Opportunity
Chapter 5 Global Contract Manufacture Organization (CMO) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Contract Manufacture Organization (CMO) Market Size Forecast by Type
5.2.1 Active Pharmaceutical Ingredients (APIs)
5.2.2 Finished Dose Formulations (FDFs)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Contract Manufacture Organization (CMO) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Contract Manufacture Organization (CMO) Market Size Forecast by Applications
6.2.1 Pharmaceutical Industry
6.2.2 Biotechnology
6.2.3 Medical Device Industry
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Contract Manufacture Organization (CMO) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Contract Manufacture Organization (CMO) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Contract Manufacture Organization (CMO) Analysis and Forecast
9.1 Introduction
9.2 North America Contract Manufacture Organization (CMO) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Contract Manufacture Organization (CMO) Market Size Forecast by Type
9.6.1 Active Pharmaceutical Ingredients (APIs)
9.6.2 Finished Dose Formulations (FDFs)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Contract Manufacture Organization (CMO) Market Size Forecast by Applications
9.10.1 Pharmaceutical Industry
9.10.2 Biotechnology
9.10.3 Medical Device Industry
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Contract Manufacture Organization (CMO) Analysis and Forecast
10.1 Introduction
10.2 Europe Contract Manufacture Organization (CMO) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Contract Manufacture Organization (CMO) Market Size Forecast by Type
10.6.1 Active Pharmaceutical Ingredients (APIs)
10.6.2 Finished Dose Formulations (FDFs)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Contract Manufacture Organization (CMO) Market Size Forecast by Applications
10.10.1 Pharmaceutical Industry
10.10.2 Biotechnology
10.10.3 Medical Device Industry
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Contract Manufacture Organization (CMO) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Contract Manufacture Organization (CMO) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Contract Manufacture Organization (CMO) Market Size Forecast by Type
11.6.1 Active Pharmaceutical Ingredients (APIs)
11.6.2 Finished Dose Formulations (FDFs)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Contract Manufacture Organization (CMO) Market Size Forecast by Applications
11.10.1 Pharmaceutical Industry
11.10.2 Biotechnology
11.10.3 Medical Device Industry
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Contract Manufacture Organization (CMO) Analysis and Forecast
12.1 Introduction
12.2 Latin America Contract Manufacture Organization (CMO) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Contract Manufacture Organization (CMO) Market Size Forecast by Type
12.6.1 Active Pharmaceutical Ingredients (APIs)
12.6.2 Finished Dose Formulations (FDFs)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Contract Manufacture Organization (CMO) Market Size Forecast by Applications
12.10.1 Pharmaceutical Industry
12.10.2 Biotechnology
12.10.3 Medical Device Industry
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Market Size Forecast by Type
13.6.1 Active Pharmaceutical Ingredients (APIs)
13.6.2 Finished Dose Formulations (FDFs)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Contract Manufacture Organization (CMO) Market Size Forecast by Applications
13.10.1 Pharmaceutical Industry
13.10.2 Biotechnology
13.10.3 Medical Device Industry
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Contract Manufacture Organization (CMO) Market: Competitive Dashboard
14.2 Global Contract Manufacture Organization (CMO) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza
14.3.2 Boehringer Ingelheim
14.3.3 Catalent
14.3.4 Baxter
14.3.5 AbbVie
14.3.6 Pfizer
14.3.7 Evonik
14.3.8 Fareva group
14.3.9 Aenova
14.3.10 Almac
14.3.11 Delpharm
14.3.12 Recipharm
14.3.13 Aesica
14.3.14 NIPRO CORPORATION
14.3.15 Daito Pharmaceutical
14.3.16 Teva API
14.3.17 Esteve Quimica
14.3.18 Euticals
14.3.19 Zhejiang Hisun Pharmaceuticals